How we used behavioural economic theory to reveal fresh insights into patient compliance
Our client currently has a product for a chronic rare disease which has seen an initial successful uptake. HCPs appear to support the product and are actively prescribing it to suitable patients.
However, sales data suggests that repeat prescriptions drastically reduce after the first 3-6 months. Although the product has a known SE profile, our client believes that this can be well managed and controlled.
Live webinar: Optimise your digital assets with UX research
Thursday 25th October 2018 11:00 EDT / 16:00 BST / 17:00 CEST
The healthcare industry is increasingly using digital channels to deliver information and services to its’ customers. But for these to be communicated effectively, in a way that increases brand loyalty, it’s critical that patients, HCPs, and any other stakeholders have a positive user experience. Conducting UX research can help ensure the products or services being delivered through various digital touch points are designed in way that brings real value to the consumer and results in a positive brand experience.
Dónde estoy, onde estou, où suis-je, where am I?
Defining the regions of Latin America and the Caribbean
Although we have conducted a lot of research studies in Latin America and the Caribbean, we couldn’t, as a team, agree exactly what defines this region and its boundaries for our clients. This is because our clients structure their LATC divisions in different ways. They often decide how to structure themselves based on where the best talent is located within the region and then balance that against proximity to strategic regions and US offices. As a result LATC operational teams vary by organisation. There is no standard blue print.
HIV Market Snapshot infographic
Our latest HIV market snapshot, reveals that 2 in 3 patients are currently treated with an STR (Single-tablet regimen) and more than half are treated with InSTIs (Integrase strand transfer inhibitors). Therapy Watch HIV patient data is collected bi-monthly from a panel of 225 physicians across the main 5 EU markets.
A common reality: How augmented reality is transforming the future of pharmaceutical marketing
In the second installment of a three-part series exploring virtual and augmented reality, Harrison Gaiger explores the ways in which augmented reality is transforming the future of pharmaceutical marketing.
In a previous article I explored the growing role that Virtual Reality (VR) is playing in the healthcare industry, including its use as a marketing tool for pharmaceutical companies, and questioned what the future of VR may look like in a world where technological advancements are being made every day. It seemed clear to me that while VR is still in the early stages of medical application, it’s already making a huge impact on the healthcare industry and that, regardless of its infancy, VR technology is most likely here to stay. Because of this I concluded by saying that tech-savvy pharmaceutical marketers should consider adding it to their future strategies as an invaluable means for engaging with customers. In the second instalment of this three-part series, I look at the ways in which Augmented Reality (AR) is transforming the future of pharmaceutical marketing.